Prothrombin 20210 mutation thrombophilia
We’re all in this for good.
- help each other live better and uncover the best ways to manage your health today
- help researchers shorten the path to new treatments tomorrow
How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.
What is prothrombin 20210 mutation thrombophilia?
Prothrombin 20210 Mutation Thrombophilia is a condition in which a person forms blood clots more than normal due to the due to a genetic mutation of the F2 gene (G20210A) .
Common symptoms reported by people with prothrombin 20210 mutation thrombophilia
Common symptoms
How bad it is
What people are taking for it
Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:
Treatments taken by people with prothrombin 20210 mutation thrombophilia
Treatment name(s)
Type
How many have tried
Tried for
Data from patients with prothrombin 20210 mutation thrombophilia, who reported starting treatments within the last 5 years.
Last updated:
Compare treatments taken by people with prothrombin 20210 mutation thrombophilia
Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Perceived effectiveness
for prothrombin 20210 mutation thrombophilia (1 evaluation)
Side effects
Total evaluations
1
Tried for
prothrombin 20210 mutation thrombophilia
(1)
Perceived effectiveness
No evaluations
Side effects
dizziness
drowsiness
Total evaluations
1
Tried for
pain
(1)
- Major
- Moderate
- Slight
- None
- Can't tell
- Severe
- Moderate
- Mild
- None
Data from patients with prothrombin 20210 mutation thrombophilia, who reported starting treatments within the last 5 years.
Last updated:
Who has prothrombin 20210 mutation thrombophilia on PatientsLikeMe?
- 14 patients have this condition
- 1 new patients joined this month
- 4 say prothrombin 20210 mutation thrombophilia is their primary condition
| Age | Proportion | # of patients |
|---|---|---|
| <20 | 0 | |
| 20s | 1 | |
| 30s | 1 | |
| 40s | 3 | |
| 50s | 6 | |
| 60s | 1 | |
| 70+ | 1 |
| Age at first symptom | Proportion | # of patients |
|---|---|---|
| 0-19 years | 2 | |
| 20-29 years | 2 | |
| 30-39 years | 1 | |
| 40-49 years | 0 | |
| 50-59 years | 0 | |
| 60-69 years | 1 | |
| 70+ years | 0 |
Distribution of sex
| Sex | Proportion | # of patients |
|---|---|---|
| Male | 3 | |
| Female | 10 |
| Diagnosis status | Proportion | # of patients |
|---|---|---|
| Diagnosed | 7 | |
| Not Diagnosed | 0 |
These charts show data from prothrombin 20210 mutation thrombophilia patients who have completed their condition history
Last updated: